NEW YORK – Diagnostics commercialization and data analytics firm Diaceutics has seen notable declines in the number of newly diagnosed cancer patients in the month of March amid the COVID-19 pandemic.
NEW YORK – Diagnostics commercialization and data analytics firm Diaceutics has seen notable declines in the number of newly diagnosed cancer patients in the month of March amid the COVID-19 pandemic.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.